T126234-50mgTAK-285
面议
- 阿拉丁
- 生产商
- T126234-50mg
- 现货
- 全国
规格 |
---|
耗材描述
- 分子式 C26H25ClF3N5O3
- 分子量547.96
属性
溶解性 |
|
存贮条件 | 储存温度-20°C |
描述
备注 | TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1. |
生化机理 |
TAK-285 is a novel dual HER2 and EGFR inhibitor with IC50 of 17 nM and 23 nM, respectively. A Phase I study of TAK-285 in patients with advanced cancer has been completed. TAK-285 is a novel, orally active, dual HER2/EGFR inhibitor with antitumor activity in mouse xenograft models, including breast, gastric, lung, and colon cancer. |
别名 | N-(2-(4-(3-chloro-4-(3-(trifluoromethyl)phenoxy)phenylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide;N-(2-(4-(3-chloro-4-(3-(trifluoromethyl)phenoxy)phenylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide |
猜你喜欢
感兴趣产品